Primary Squamous Cell Carcinoma of the Breast is a Rare and Special Entity
A Case Report from Arab Region with Aggressive Behavior and follow up 25 Months
DOI:
https://doi.org/10.6000/1927-7229.2018.07.03.1Keywords:
Squamous cell carcinoma of the breast (SCCB), chemotherapy, rare malignancyAbstract
Background: Primary squamous cell carcinoma of the breast (PSCCB) is a very rare malignancy of the breast. Pure squamous cell carcinoma of the breast can originate from skin adnexa, the nipple or the epithelium of deep-seated epidermoid cyst or squamous metaplasia on chronic inflammation background.
Case Report: Our case is a 49-year-old female patient who presented with a highly suspicious lump in her left breast. Bilateral mammography and core biopsy were carried out. The core biopsy was revealed atypical cells and review inconclusive. Incisional biopsy was done and revealed squamous cell carcinoma of the breast (SCCB). Her metastatic work up at presentation was unremarkable. Left-side modified radical mastectomy was carried out. TNM staging was Stage IIa pT2N0M0 GIII, Estrogen receptors (ER) and Progesterone receptors were negative and HER2/Neu was negative as well (Triple negative). Pt had adjuvant chemotherapy and radiotherapy. Eight months later, she developed multiple brain metastasis as solitary site of metastasis, then after four months she developed hepatic and pulmonary deposits. Pt survived only 25 months since disease diagnosis.
We report this case with relatively younger age to confirm that primary squamous cell carcinoma of the breast has special aggressive entity and this conjugant with few series. The treatment of primary SqCC of the breast does not differ from other common histological types of breast cancer so far.
Conclusions: The prognosis of this disease is highly uncertain and the treatment options are unclear and controversial. There is inadequate literature and treatment guidelines. To our knowledge it is the first case to be reported from arab region with aggressive behavior and short survival period.
References
Louwman MW, Vriezen M, van Beek MW. Uncommon breast tumors in perspective: Incidence, treatment and survival in the Netherlands. Int J Cancer 2007; 121: 127-135. https://doi.org/10.1002/ijc.22625
Tavassoli FA, Devilee P, editors. Tumours of the Breast and Female Genital Organs. Lyon, France: IARC Press; 2003. World Health Organization Classification of Tumours. Pathology and Genetics; p. 1-433
Vu-Nishino H, Tavassoli FA, Ahrens WA, Haffty BG. Clinicopathologic features and long-term outcome of patients with medullary breast carcinoma managed with breast-conserving therapy (BCT). Int J Radiat Oncol Biol Phys 2005; 62(4): 1040-1047. https://doi.org/10.1016/j.ijrobp.2005.01.008
Kim MJ, Ro JY, Ahn SH, Kim HH, Kim SB, Gong G. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes. Hum Pathol 2006; 37(9): 1217-1226. https://doi.org/10.1016/j.humpath.2006.04.015
Behranwala KA, Nasiri N, Abdullah N: Squamous cell carcinoma of the breast: Clinico-pathologic implications and outcome. Eur J Surg Oncol 2003; 29: 386-389. https://doi.org/10.1053/ejso.2002.1422
Yerushalmi R, Hayes MM, Gelmon KA. Breast carcinoma—rare types: review of the literature Ann Oncol 2009; 20(11): 1763-1770. First published online July 14, 2009. https://doi.org/10.1093/annonc/mdp245
Tayeb K, Saadi I, Kharmash M, El Omari-Alaoui H, El Ghazi E, Mansouri A,: Primary squamous cell carcinoma of the breast: Report of three cases. Cancer Radiother 2002; 6: 366-368. https://doi.org/10.1016/S1278-3218(02)00258-5
Cardoso F, Leal C, Meira A, Azevedo R, Mauricio MJ, Leal da Silva JM, Lopes C, Pinto Ferreira E. Squamous cell carcinoma of the breast. Breast 2000; 9: 315-319. https://doi.org/10.1054/brst.1999.0145
Gupta G, Malani AK, Weigand RT, Rangenini G. Pure primary squamous cell carcinoma of the breast: A rare presentation and clinicopathologic comparison with usual ductal carcinoma of the breast. Pathol Res Pract 2006; 6: 465-69. https://doi.org/10.1016/j.prp.2006.01.006
Moisidis E, Ahmed S, Carmalt H, et al. Primary squamous cell carcinoma of the breast. ANZ J Surg 2002; 72: 65-67. https://doi.org/10.1046/j.1445-2197.2002.02298.x
Murialdo R, Boy D, Musizzano Y, Tixi L, Murelli F, Ballestrero A. Squamous cell carcinoma of the breast: a case report. Cases Journal 2009; 2: 7336-7339.
Grenier J, Soria JC, Mathieu MC, Andre F, Abdelmoula S, Velasco V, Morat L, et al. Differential immunohistochemical and biological profile of squamous cell carcinoma of the breast. Anticancer Res 2007; 27(1B): 547-555.
Menes T, Schachter J, Morgenstern S: Primary squamous cell carcinoma (SqCC) of the breast. Am J Clin Oncol 2003; 26: 571-573. https://doi.org/10.1097/01.coc.0000045809.85995.3B
Hennessy BT, Krishnamurthy S, Giordano S, Buchholz TA, Kau SW, Duan Z, Valero V, Hortobagyi GN. Squamous cell carcinoma of the breast. J Clin Oncol 2005; 23: 7827-7835. https://doi.org/10.1200/JCO.2004.00.9589
Geyer FC, Weigelt B, Natrajan R, Lambros MB, de Biase D, Vatcheva R, Savage K, et al. Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas. J Pathol 2010; 220(5): 562-573. https://doi.org/10.1002/path.2675
Banerjee S, Reis-Filho JS, Ashley S, Steele D, Ashworth A, Lakhani SR, Smith IE. Basal-like breast carcinomas: clinical outcome and response to chemotherapy. J Clin Pathol 2006; 59(7): 729-735. https://doi.org/10.1136/jcp.2005.033043
Yamaguchi R, Horii R, Maeda I, Suga S, Makita M, Iwase T, Oguchi M, et al. Clinicopathologic study of 53 metaplastic breast carcinomas: their elements and prognostic implications. Hum Pathol 2010; 41(5): 679-685. https://doi.org/10.1016/j.humpath.2009.10.009
Tsung S. Primary Pure Squamous Cell Carcinoma of the Breast Might Be Sensitive to Cisplatin-Based Chemotherapy. Case Rep Oncol 2012; 5(3): 561-565. https://doi.org/10.1159/000343745
Downloads
Published
Issue
Section
How to Cite
Similar Articles
- Arunima Ghosh, Karlena Lara-Otero, Marston W. Linehan , Maria J. Merino , Can Mutations in the BAP1 Gene be Detected by Immunohisto-chemistry in Hereditary Kidney Cancers? , Journal of Analytical Oncology: Vol. 3 No. 3 (2014)
- Sally McLaren, Frank Arfuso, Nik Zeps, Arun Dharmarajan, The Role of Secreted Frizzled Related Protein 4 (sFRP-4) in Regulating Oestradiol-Induced Growth of the MCF-7 Breast Cancer Cell Line , Journal of Analytical Oncology: Vol. 3 No. 1 (2014)
- Alexandra Lykhova, Natalia Bezdenezhnykh, Nadiia Semesiuk, Inna Adamenko, Ada Vorontsova , Yuri Kudryavets , Loss of Malignancy in Mouse Melanoma Cells by Long-Term Impact of Interferon-Beta In Vitro is Associated with N- and VE-Cadherins Suppression without Inhibition of Expression of EMT-Associated Twist and Slug Proteins , Journal of Analytical Oncology: Vol. 3 No. 3 (2014)
- Anna Haydee Chacon, Uzma Farooq, Katlein Franca, Jennifer Ledon, Jessica Savas, Keyvan Nouri, Reflectance Confocal Microscopy - Real-Time In Vivo Imaging of Basal and Squamous Cell Carcinomas , Journal of Analytical Oncology: Vol. 1 No. 2 (2012)
- Palak Lunkad, Deepika Malik, Sahil Shah, Mohini Gurjar, Virendra Bhandari, Incidental Diagnosis of Leptomeningeal Disease in Breast Cancer with Brain Metastases- a Case Report with Review of Literature , Journal of Analytical Oncology: Vol. 14 (2025)
- Neizekhotuo Brian Shunyu, Gautam Sarma, Hanifa Akhtar, Ratan Medhi, Reconstruction of Advanced Basal Cell Carcinoma of the Face: Case Report , Journal of Analytical Oncology: Vol. 14 (2025)
- Rahul G. Dholariya, Ankur Tripathi, Amritha Prabha Shankar, M.S. Ganesh, Ravoori Harish Babu, Prevalence and Type Distribution of Human Papilloma Virus (HPV) in Oral, Oropharyngeal, Cervical, and Vulvovaginal Cancers , Journal of Analytical Oncology: Vol. 14 (2025)
- Jianwen Lin, Jiali Yang, Jianjun Lu, Xiaoyi Hao, Jiawei Liu, Huali Yan, Huayi Li, Yu Guo, Yong Gu, Quanyong Cheng, Clinical Features of de Novo Lung Neuroendocrine Tumor after Liver Transplantation for Hepatocellular Carcinoma , Journal of Analytical Oncology: Vol. 11 (2022)
- Cardile Venera , Avola Rosanna, C.E. Graziano Adriana, Madrid Alejandro, Russo Alessandra, Boldine Activates Intrinsic Apoptotic Pathway in DU-145 Androgen-Independent Prostate Cancer Cell Line , Journal of Analytical Oncology: Vol. 8 (2019)
- Ravoori Harish Babu, Amritha Prabha Shankar, Geeta S. Narayanan, Ganesh M. Subramanya, B.R. Kiran Kumar, Association of Level III Axillary Lymph Node Positivity with Clinicopathological Characteristics in Breast Cancer , Journal of Analytical Oncology: Vol. 13 (2024)
You may also start an advanced similarity search for this article.
Most read articles by the same author(s)
- Jamal Zekri, Syed Mustafa Karim, Ahmed Al-Shehri, Mervat Mahrous, Tarek Darwish, Hani El Taani, Frequency and Clinical Impact of KRAS Mutations in Patients with Colorectal Cancer from the Middle East , Journal of Analytical Oncology: Vol. 5 No. 2 (2016)